Biotech's biggest blockbusters

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Biotech's biggest blockbusters

biotech-pioneers-puff.gif

It has been just over three decades since the first biotechnology company - Genentech - was formed in 1976. Since then biotechnology has become a multi-billion dollar industry with ground-breaking products, based on original research. Eklavya Gupte examines five patents that have shaped the sector

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login
more from across site and ros bottom lb

More from across our site

Managing IP goes behind the scenes to uncover what happens when setting up an SEP licensing programme for electric vehicle chargers, and discovers why law firms play a crucial role
Exclusive data and in-house analysis show that law firms are able to respond quickly when engaging with in-house clients but struggle to make the grade when it comes to the quality of their answers
Penelope Aspinall, of wellbeing charity Jonathan’s Voice, explains why a newly published mental health hub for the IP community could prove to be a vital resource
The dispute, which centres on the patentability of a computer program, has seen multiple twists and turns
Paul Hastings said the hire of litigator Alex Morgan underscores the firm’s commitment to strengthening its London-based IP team
The Unified Patent Court’s first FRAND judgment, a patent blow for Samsung, and a new design law treaty were among the top IP stories this week
Leaders at Morgan Lewis discuss the firm’s bold ambitions for Europe and why it feels it can offer a boutique experience within a full-service setting
Firms in Canada explain how they’ve adapted to a rule change in 2017 that has made advocacy skills more important in pharma disputes
Leaders at some IP businesses are looking to consolidate the fragmented market and, considering the benefits, their rivals may want to follow suit
Counsel at three US firms explain how they are expanding their UPC teams or if they are looking to partner with European firms
Gift this article